Showing results (181-190 of 523) with videos related to

Sort By:
Pageof 53
Blood Pressure Monitoring|April 7, 2005
24-hour ambulatory blood-pressure effects of valsartan and hydrochlorothiazide combinations compared with amlodipine in hypertensive patients at increased cardiovascular risk: a VAST sub-studyLuis M Ruilope, Daniela Heintz, Andrea A Brandão, et al.
Blood Pressure. Supplement|August 19, 2008
Public health value of fixed-dose combinations in hypertensionLuis M Ruilope, Michel Burnier, Noemi Muszbek, et al.
European Journal of Clinical Investigation|November 7, 2015
Ambulatory blood pressure monitoring in daily clinical practice - the Spanish ABPM Registry experienceManuel Gorostidi, José R Banegas, Alejandro de la Sierra, et al.
Frontiers in Physiology|December 6, 2021
Fibroblast Growth Factor-23-Klotho Axis in Cardiorenal Syndrome: Mediators and Potential Therapeutic TargetsJosé Alberto Navarro-García, Laura González-Lafuente, María Fernández-Velasco, et al.
Blood Pressure|February 7, 2004
Hyperuricemia, low urine urate excretion and target organ damage in arterial hypertensionCarlos Campo, Luis M Ruilope, Julian Segura, et al.
Nature Reviews. Cardiology|May 12, 2017
Has the SPRINT trial introduced a new blood-pressure goal in hypertension?Gema Ruiz-Hurtado, José R Banegas, Pantelis A Sarafidis, et al.
Journal of Hypertension|June 13, 2025
Mortality risks in different subtypes of white-coat hypertension: implications for the diagnosis of white-coat hypertensionAlejandro de la Sierra, Luis M Ruilope, Natalie Staplin, et al.
The Journal of Clinical Endocrinology and Metabolism|October 21, 2020
Effect of Treatment of Periodontitis on Incretin Axis in Obese and Nonobese Individuals: A Cohort StudyJeanie Suvan, Stefano Masi, Zoe Harrington, et al.
Cardiovascular Diabetology|December 31, 2025
Dapagliflozin modulates plasma lipidomic profile and urinary metabolite excretion in type 2 diabetesSamantha Pezzica, Filippo Pratesi, Silvia Sabatini, et al.
Frontiers in Endocrinology|June 5, 2023
Canagliflozin on top of dual renin-angiotensin system blockade in a woman with partial acquired lipodystrophy, type 2 diabetes and severely proteinuric chronic kidney disease: a case reportEdoardo Biancalana, Giovanni Ceccarini, Silvia Magno, et al.
Pageof 53